AtriCure officer plans $408K stock sale

AtriCure officer Salvatore Privitera filed a Rule 144 notice to sell 7,763 vested restricted shares valued at about $407,557.50.

Rhea-AI Filing Summary

AtriCure, Inc. (ATRC) received a notice that officer Salvatore Privitera intends to sell 7,763 shares of common stock under Rule 144. The shares were acquired from the issuer as restricted stock that vested during the period from March 1, 2020 through March 1, 2021. The proposed sale, through Morgan Stanley Smith Barney’s Executive Financial Services unit, reflects an estimated aggregate market value of $407,557.50 and is associated with trading on NASDAQ.

Key Figures

Shares to be sold: 7,763 shares Estimated aggregate market value: $407,557.50 Vesting period for restricted stock: March 1, 2020 – March 1, 2021 +1 more

4 metrics

Shares to be sold 7,763 shares Common stock proposed for sale under Rule 144 by officer Salvatore Privitera

Estimated aggregate market value $407,557.50 Value associated with the 7,763 AtriCure common shares to be sold

Vesting period for restricted stock March 1, 2020 – March 1, 2021 Period during which the restricted stock being sold vested

Date of notice September 2, 2026 Date associated with the Rule 144 notice filing for the planned sale

Key Terms

Rule 144, restricted stock, aggregated

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock financial

"The securities to be sold were acquired upon the vesting of restricted stock"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

aggregated regulatory

"sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated"

FAQ

What did AtriCure (ATRC) disclose in this Rule 144 filing?

AtriCure disclosed that officer Salvatore Privitera filed a Rule 144 notice to sell 7,763 shares of AtriCure common stock that were acquired as restricted stock from the issuer and vested between March 1, 2020 and March 1, 2021.

How many AtriCure (ATRC) shares are covered by Salvatore Privitera’s planned sale?

The notice covers a proposed sale of 7,763 shares of AtriCure common stock. These shares were originally received as restricted stock and later vested over the period from March 1, 2020 through March 1, 2021.

What is the estimated value of the AtriCure (ATRC) shares in this Rule 144 filing?

The filing reports an estimated aggregate market value of $407,557.50 for the 7,763 AtriCure common shares to be sold. This value reflects the approximate market worth associated with the proposed Rule 144 sale.

When were the AtriCure (ATRC) shares acquired that are now being registered for sale?

The shares to be sold were acquired as restricted stock from AtriCure with vesting occurring during the period from March 1, 2020 through March 1, 2021, according to the remarks in the notice.

Which broker is involved in handling the AtriCure (ATRC) Rule 144 sale for Salvatore Privitera?

The Rule 144 sale is associated with Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY, as identified in the securities information section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 05:15 PM Accepted by SEC EDGAR 09/02/2026 - 05:15 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001336063
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ATRICURE, INC.
SEC File Number	000-51470
Address of Issuer	7555 Innovation Way Mason OHIO 45040
Phone	(513) 755-4100
Name of Person for Whose Account the Securities are To Be Sold	SALVATORE PRIVITERA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7763	407557.50	50866294	09/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2020	Restricted Stock	ISSUER			7763	03/01/2020	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock during the period of 03/01/2020 through 03/01/2021
Date of Notice	09/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Salvatore Privitera
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)